Lupin launches Lapatinib Tablets
They are indicated in combination with Capecitabine or Letrozole to treat breast cancer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US FDA approval
Eton Pharma gets US FDA approval for orphan drug ALKINDI SPRINKLE (hydrocortisone)
It is indicated as replacement therapy in paediatric patients with adrenocortical insufficiency
USFDA approves Nucala to treat hypereosinophilic syndrome
The approval granted to GlaxoSmithKline is the first approval for HES patients in nearly 14 years
Cipla gets US FDA approval for dimethyl fumarate DR capsules
It is indicated for the treatment of relapsing forms of multiple sclerosis
Zydus Cadila gets US FDA approval for Doxorubicin Hydrochloride Liposome Injection
Liposomal doxorubicin is a chemotherapeutic agent that is used alone or with other treatments/medications to treat certain types…
Alembic Pharma gets tentative USFDA approval for Treprostinil injection
It is indicated for the treatment of pulmonary arterial hypertension to diminish symptoms associated with exercise
Roche’s Genentech gets US FDA approval for Gavreto (pralsetinib)
The drug is used to treat metastatic RET fusion-positive non-small cell lung cancer
Strides gets USFDA approval for Ursodiol tablets
Product to be launched immediately and marketed by Strides Pharma in the US market
US FDA approves Novartis Kesimpta (ofatumumab) for relapsing forms of MS treatment
Ofatumumab was first approved by the FDA in 2009 for the treatment of chronic lymphocytic leukaemia (CLL)
Mylan announces launch of generic version of Biogen’s Tecfidera
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)